Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Amneal Pharmaceuticals Inc. (AMRX)

2.71   -0.15 (-5.24%) 08-20 10:21
Open: 2.89 Pre. Close: 2.86
High: 2.9 Low: 2.685
Volume: 524,582 Market Cap: 844M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.893 - 2.904 2.904 - 2.917
Low: 2.354 - 2.365 2.365 - 2.376
Close: 2.838 - 2.857 2.857 - 2.879

Technical analysis

as of: 2019-08-20 9:57:33 AM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.87     One year: 4.54
Support: Support1: 2.38    Support2: 1.98
Resistance: Resistance1: 3.31    Resistance2: 3.89
Pivot: 2.94
Moving Average: MA(5): 2.62     MA(20): 3.11
MA(100): 7.98     MA(250): 13.41
MACD: MACD(12,26): -0.59     Signal(9): -0.69
Stochastic oscillator: %K(14,3): 22.29     %D(3): 12.03
RSI: RSI(14): 33.44
52-week: High: 24.48  Low: 2.38  Change(%): -88.0
Average Vol(K): 3-Month: 197806  10-Days: 194945

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
AMRX has closed above bottom band by 43.2%. Bollinger Bands are 51.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to AMRX's normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 12 Aug 2019 20:56:35 Z
After Hours Most Active for Aug 12, 2019 : PENN, RIG, MSFT, AKAM, JD, NWL, WFC, CZR, ECA, AMRX, TEVA, SRE

Mon, 05 Aug 2019 18:08:11 Z
Amneal Pharmaceuticals (AMRX) Q2 Earnings and Revenues Lag Estimates

Thu, 01 Aug 2019 17:04:25 Z
Analysts Estimate Amneal Pharmaceuticals (AMRX) to Report a Decline in Earnings: What to Look Out for

Fri, 26 Jul 2019 15:17:57 Z
ASRT or AMRX: Which Is the Better Value Stock Right Now?

Thu, 11 Jul 2019 22:10:26 Z
Amneal (AMRX) Down on Guidance Update & Restructuring Plan

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 115.53
Shares Float (M) 32.60
% Held by Insiders 36.79
% Held by Institutions 101.52
Shares Short (K) 5750
Shares Short P. Month (K)

Stock Financials

EPS -0.522
EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS
Book Value (p.s.) 3.590
PEG Ratio 0.42
Profit Margin -3.65
Operating Margin 8.66
Return on Assets (ttm) 2.2
Return on Equity (ttm) -21.0
Qtrly Rev. Growth -2.2
Gross Profit (p.s.) 6.378
Sales Per Share
EBITDA (p.s.) 3.328
Qtrly Earnings Growth
Operating Cash Flow (M) 234.46
Levered Free Cash Flow (M) 194.89

Stock Valuations

P/E -5.45
P/E Growth Ratio -0.01
P/BV 0.79
P/S 22978352.00
P/CF 1.40

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.